Charles G. Drake
Johnson & Johnson (United States)(US)Columbia University Irving Medical Center(US)New Mexico Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Prostate Cancer Treatment and Research, Intracranial Aneurysms: Treatment and Complications, Immune Cell Function and Interaction
Most-Cited Works
- → Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer(2012)12,531 cited
- → Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer(2012)7,941 cited
- → Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy(2015)4,168 cited
- → Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates(2010)2,913 cited
- → A draft map of the human proteome(2014)2,281 cited
- → Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape(2011)1,624 cited